Sánchez-Delgado Jordi, Calzado Sonia, de Haro Candelaria, Mas Montse, Miquel Mireia, Casas Meritxell, Vergara Mercedes, Dalmau Blai, Gil Montserrat
Unidad de Hepatología, Servicio de Aparato Digestivo, Universitat Autònoma de Barcelona, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, España.
Gastroenterol Hepatol. 2012 Jan;35(1):12-6. doi: 10.1016/j.gastrohep.2011.11.002. Epub 2011 Dec 15.
The life expectancy of patients with hepatocellular carcinoma (HCC) has increased in the last few years due to recent treatment advances. However, extrahepatic metastases from tumors, previously described only occasionally, are becoming more frequent in clinical practice. The choice between an active or passive approach to these metastatic lesions can sometimes present clinicians with a difficult dilemma. We discuss the case of a male patient with multifocal HCC and cranial metastasis from a primary liver tumor and who, after surgery and radiotherapy over the metastatic lesion, has survived for more than 3 years.
由于近年来治疗方法的进步,肝细胞癌(HCC)患者的预期寿命有所增加。然而,肿瘤的肝外转移在过去仅偶尔被描述,现在在临床实践中变得越来越常见。对于这些转移性病变,选择积极或消极的治疗方法有时会让临床医生陷入两难困境。我们讨论了一名男性患者的病例,该患者患有多灶性HCC并伴有原发性肝癌的脑转移,在对转移病灶进行手术和放疗后,已存活超过3年。